Sub-dissociative Dose Ketamine for Analgesia Joint ENA/ACEP/SEMPA Policy Statement-Sub-dissociative Dose Ketamine for Analgesia Joint ENA/ACEP/SEMPA Policy Statement

Pdf Summary

The American College of Emergency Physicians, in collaboration with the Emergency Nurses Association and the Society of Emergency Medicine Physician Assistants, has approved a policy statement on the use of sub-dissociative dose ketamine (SDK) for analgesia. SDK, also known as low dose ketamine (LDK), is considered safe and effective for pain relief in emergency departments. Benefits of using SDK over opioids and other analgesics include improved pain relief, reduced respiratory depression, and maintenance of cardiac output. Patients should be informed that SDK administration may cause minor side effects such as nausea and temporary dysphoria. Observation and assessment of the patient's response to SDK is necessary, but special procedures or monitoring are not required due to its excellent safety profile. The administration of SDK can be done using the same policies and procedures as other analgesics. The document also references a previous policy statement on optimizing the treatment of acute pain in the emergency department, which mentions that SDK can be used either alone or as part of a multimodal approach to pain relief for both traumatic and non-traumatic pain. Overall, SDK is considered a valuable option for pain management in the emergency setting.

Meta Tag

ketamine medication

ketamine meds

ketamine drug

ketamine naloxone

ketamine ketamine

ketamine analgesics

ketamine SDK

ketamine pain

ketamine trauma

Keywords

American College of Emergency Physicians

Emergency Nurses Association

Society of Emergency Medicine Physician Assistants

sub-dissociative dose ketamine

low dose ketamine

analgesia

pain relief

opioids

respiratory depression

cardiac output